| 30.09.2024 ARCH Venture Partners closes latest fund on $3 billion |
| Bailey McCann, Opalesque New York: ARCH Venture Partners has closed its third fund ARCH Venture Fund XIII on approximately $3 billion. The fund will focus on investments in the founding and growth of early-stage biotechnology companies. Fund XIII follows the $2.975 billion Fund XII announced in June 2022. "We believe AI and new data-driven insights into biology will help to enable |
| Article source: https://www.archventure.com/arch-venture-partners-announces-new-fund-xiii/ - Opalesque is not responsible for the content of external internet sites |